Graphite Bio, Inc. (GRPH): Price and Financial Metrics

Graphite Bio, Inc. (GRPH): $22.26

0.63 (-2.75%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add GRPH to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#72 of 359

in industry

GRPH Price/Volume Stats

Current price $22.26 52-week high $22.62
Prev. close $3.27 52-week low $2.01
Day low $21.35 Volume 46,900
Day high $22.62 Avg. volume 282,405
50-day MA $3.03 Dividend yield N/A
200-day MA $2.62 Market Cap 1.30B

GRPH Stock Price Chart Interactive Chart >


Graphite Bio, Inc. (GRPH) Company Bio


Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression; GPH201 for the treatment of X-linked severe combined immunodeficiency syndrome; and GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.


GRPH Latest News Stream


Event/Time News Detail
Loading, please wait...

GRPH Latest Social Stream


Loading social stream, please wait...

View Full GRPH Social Stream

GRPH Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 37.07%
3-year -65.02%
5-year N/A
YTD 21.37%
2023 -21.08%
2022 -73.29%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!